Related Experiment Video
Updated: May 3, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
BMAL1-dependent regulation of the mTOR signaling pathway delays aging
Rohini V Khapre1, Anna A Kondratova, Sonal Patel
1Center for Gene Regulation in Health and Diseases, BGES, Cleveland State University, Cleveland, OH.
Abstract:
The circadian clock, an internal time-keeping system, has been linked with control of aging, but molecular mechanisms of regulation are not known. BMAL1 is a transcriptional factor and core component of the circadian clock; BMAL1 deficiency is associated with premature aging and reduced lifespan. Here we report that activity of mammalian Target of Rapamycin Complex 1 (mTORC1) is increased upon BMAL1 deficiency both in vivo and in cell culture. Increased mTOR signaling is associated with accelerated aging; in accordance with that, treatment with the mTORC1 inhibitor rapamycin increased lifespan of Bmal1-/- mice by 50%. Our data suggest that BMAL1 is a negative regulator of mTORC1 signaling. We propose that the circadian clock controls the activity of the mTOR pathway through BMAL1-dependent mechanisms and this regulation is important for control of aging and metabolism.
Insights
The circadian clock
Area of Science:
- Chronobiology
- Molecular Biology
- Aging Research
Background:
- The circadian clock regulates physiological processes, but its role in aging is not fully understood.
- BMAL1, a core circadian clock component, is crucial for lifespan and preventing premature aging.
- Molecular mechanisms linking the circadian clock to aging remain largely unknown.
Purpose of the Study:
- To investigate the molecular mechanisms by which the circadian clock influences aging.
- To determine the role of BMAL1 in regulating aging pathways.
- To explore the connection between BMAL1, mTORC1 signaling, and lifespan.
Main Methods:
- Assessing mTORC1 activity in BMAL1-deficient mice and cell cultures.
- Utilizing BMAL1 knockout (Bmal1-/-) mouse models.
- Administering the mTORC1 inhibitor rapamycin to Bmal1-/- mice.
Main Results:
- BMAL1 deficiency leads to increased mammalian Target of Rapamycin Complex 1 (mTORC1) signaling.
- Increased mTOR signaling correlates with accelerated aging phenotypes.
- Rapamycin treatment extended the lifespan of Bmal1-/- mice by 50%.
Conclusions:
- BMAL1 acts as a negative regulator of mTORC1 signaling.
- The circadian clock, via BMAL1, modulates mTOR pathway activity.
- This BMAL1-dependent regulation of mTOR is vital for controlling aging and metabolism.
More Related Videos
09:29Isolation of Intermediate Filament Proteins from Multiple Mouse Tissues to Study Aging-associated Post-translational Modifications
Published on: May 18, 2017
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...